12:00 AM
 | 
Dec 24, 2012
 |  BC Week In Review  |  Company News  |  Other News

Amgen hematology news

Amgen will pay $612 million to resolve civil liability related to promotional activities for six of its drugs, including anemia drugs Aranesp darbepoetin alfa and Epogen epoetin alfa. The company...

Read the full 158 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >